print

News

All Releases
Curis Reports CUDC-907 and CUDC-427 Data at AACR Annual Meeting 2014
Apr 7, 2014
PDF 75.5 KB Add to Briefcase
Curis and Debiopharm Group(TM) Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014
Apr 7, 2014
PDF 11.2 KB Add to Briefcase
Curis to Present at the 13th Annual Needham Healthcare Conference
Apr 2, 2014
PDF 7.1 KB Add to Briefcase
Curis Announces Removal of FDA Partial Clinical Hold on CUDC-427
Mar 31, 2014
PDF 10.3 KB Add to Briefcase
Curis Announces Presentation of Data for CUDC-907, CUDC-427 and Debio 0932 at AACR Annual Meeting
Mar 31, 2014
PDF 8.7 KB Add to Briefcase
Curis to Present at the 26th Annual ROTH Conference
Mar 4, 2014
PDF 7.1 KB Add to Briefcase
Curis to Present at the Cowen and Company 34th Annual Health Care Conference
Feb 25, 2014
PDF 7.1 KB Add to Briefcase
Curis Reports Fourth Quarter and Year-End 2013 Financial Results
Feb 20, 2014
PDF 22.5 KB Add to Briefcase
Curis to Present at the RBC Capital Markets Global Healthcare Conference
Feb 19, 2014
PDF 6.9 KB Add to Briefcase
Curis to Release Fourth Quarter and Year End 2013 Financial Results and Hold Conference Call on February 20, 2014
Feb 13, 2014
PDF 6.8 KB Add to Briefcase
Curis to Present at the Leerink Global Healthcare Conference
Feb 5, 2014
PDF 7.1 KB Add to Briefcase
Curis Reports CUDC-907 Preliminary Data From the Ongoing Phase 1 Trial at ASH 2013 Annual Meeting
Dec 9, 2013
PDF 59.6 KB Add to Briefcase
Curis to Present at the Oppenheimer 24th Annual Healthcare Conference
Dec 4, 2013
PDF 7.2 KB Add to Briefcase
Curis to Present at Upcoming Investor Conferences
Nov 26, 2013
PDF 7.7 KB Add to Briefcase
Curis Reports Third Quarter 2013 Financial Results and Provides CUDC-427 Development Update
Nov 6, 2013
PDF 26.4 KB Add to Briefcase
Curis and Debiopharm Group Announce Initiation of Phase I Dose Finding Clinical Study With a Combination of HSP90 Inhibitor Debio 0932 and Everolimus
Oct 22, 2013
PDF 12.5 KB Add to Briefcase
Curis Announces Initiation of a Roche-Sponsored Phase 1b/2 Study of Erivedge(R) (vismodegib) in Relapsed/Refractory AML and High Risk MDS
Oct 4, 2013
PDF 11.1 KB Add to Briefcase
Curis to Webcast Investor and Analyst Day in New York City
Sep 26, 2013
PDF 6.6 KB Add to Briefcase
Curis to Present at Upcoming Investor Conferences
Sep 4, 2013
PDF 7.5 KB Add to Briefcase
Curis Strengthens Leadership Team With Appointments of Jaye Viner, M.D. as Chief Medical Officer and Tania Chander, Pharm.D. as VP of Product Development
Aug 13, 2013
PDF 10.5 KB Add to Briefcase
Showing 1-20 of 253 Page: 1 2 3 4 5 ... 13  Next 20
Add to Briefcase = add file to Briefcase

© Curis Inc. 2014 - All Rights Reserved